Use of sclerosing agent in the management of oral and perioral hemangiomas: Review and case reports

Heba Selim, Abdulhafez Selim, Amor Khachemoune, Salah Abdel Fattah A. Metwally*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Background: Most cutaneous hemangiomas involute spontaneously. However, the lesion existing on the face poses a cosmetic problem while waiting for involution. Case Reports: Three hemangioma cases were treated by repeated local injection of 5% ethanolamine oleate solution. The lesions flattened and markedly reduced in size as shown by clinical and imaging evaluation. Conclusions: Use of 5% ethanolamine oleat as a sclerosing agent for repeated intralesional injection in the management of facial hemangiomas is a safe treatment with acceptable results. As presented here, this technique offers the patient considerable relief of symptoms with minimal complications. However, the possibility of second-stage surgery to correct residual deformity is still considered. Sclerotherapy with ethanolamine oleate provides a good preparation for further surgery.

Original languageEnglish
Pages (from-to)CS114-CS119
JournalMedical Science Monitor
Volume13
Issue number9
StatePublished - Sep 2007

Keywords

  • Ethanolamine oleate
  • Oral and perioral hemangioma
  • Sclerosing agent

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Use of sclerosing agent in the management of oral and perioral hemangiomas: Review and case reports'. Together they form a unique fingerprint.

Cite this